汉森制药：关于取得换发《药品生产许可证》的公告

Core Viewpoint - The company has received a renewed drug production license from the Hunan Provincial Drug Administration, which is valid until November 6, 2030 [2] Group 1 - The company is Hunan Hansen Pharmaceutical Co., Ltd. [2] - The announcement was made on the evening of November 17 [2] - The renewed drug production license signifies compliance with regulatory standards [2]